Li Yan, Zhao Lifen, Li Nana, Miao Yuan, Zhou Huimin, Jia Li
Department of Clinical Laboratory, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, P.R. China.
College of Laboratory Medicine, Dalian Medical University, Dalian, Liaoning 116044, P.R. China.
Oncol Rep. 2019 May;41(5):3148. doi: 10.3892/or.2019.7057. Epub 2019 Mar 13.
Following the publication of this article, the authors have subsequently realized that Fig. 2D (lower middle panel, K562‑control group treated with paclitaxel) contained the same data as the left lower panel (K562 group). The authors have examined their original data, and realize that the same data was inadvertently included in this Figure twice. Consequently, the corrected version of Fig. 2, featuring the correct data for the lower middle panel (K562‑control group treated with paclitaxel), is shown opposite. The overall conclusions of this study were not affected by this error. The authors regret that this error was introduced into the printed version of the paper, and apologize to the readership for any inconvenience caused. [the original article was published in Oncology Reports 37: 2193‑2200, 2017; DOI: 10.3892/or.2017.5464.
在本文发表之后，作者们随后意识到图2D（中下方板块，用紫杉醇处理的K562对照组）包含了与左下方板块（K562组）相同的数据。作者们检查了他们的原始数据，并意识到相同的数据在该图中被无意地包含了两次。因此，图2的校正版本如下所示，其中中下方板块（用紫杉醇处理的K562对照组）具有正确的数据。本研究的总体结论并未受到此错误的影响。作者们对该错误被引入论文印刷版本表示遗憾，并就由此给读者带来的不便向读者致歉。[原文发表于《肿瘤学报道》37: 2193 - 2200, 2017；DOI: 10.3892/or.2017.5464]
